Cargando…
SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632109/ https://www.ncbi.nlm.nih.gov/pubmed/37953953 http://dx.doi.org/10.1016/j.isci.2023.108302 |
| _version_ | 1785132507313733632 |
|---|---|
| author | Mei, Jie Fu, Ziyi Cai, Yun Song, Chenghu Zhou, Jiaofeng Zhu, Yichao Mao, Wenjun Xu, Junying Yin, Yongmei |
| author_facet | Mei, Jie Fu, Ziyi Cai, Yun Song, Chenghu Zhou, Jiaofeng Zhu, Yichao Mao, Wenjun Xu, Junying Yin, Yongmei |
| author_sort | Mei, Jie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10632109 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106321092023-11-10 SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers Mei, Jie Fu, Ziyi Cai, Yun Song, Chenghu Zhou, Jiaofeng Zhu, Yichao Mao, Wenjun Xu, Junying Yin, Yongmei iScience Correction Elsevier 2023-10-25 /pmc/articles/PMC10632109/ /pubmed/37953953 http://dx.doi.org/10.1016/j.isci.2023.108302 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Mei, Jie Fu, Ziyi Cai, Yun Song, Chenghu Zhou, Jiaofeng Zhu, Yichao Mao, Wenjun Xu, Junying Yin, Yongmei SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers |
| title | SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers |
| title_full | SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers |
| title_fullStr | SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers |
| title_full_unstemmed | SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers |
| title_short | SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers |
| title_sort | sectm1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632109/ https://www.ncbi.nlm.nih.gov/pubmed/37953953 http://dx.doi.org/10.1016/j.isci.2023.108302 |
| work_keys_str_mv | AT meijie sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT fuziyi sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT caiyun sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT songchenghu sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT zhoujiaofeng sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT zhuyichao sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT maowenjun sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT xujunying sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers AT yinyongmei sectm1isupregulatedinimmunohottumorsandpredictsimmunotherapeuticefficacyinmultiplecancers |